Efficacy of atorvastatin in primary hypercholesterolemia. Japan Cholesterol Lowering Atorvastatin Study (J-CLAS) Group.
A placebo-controlled, double-blind study on the efficacy of atorvastatin was conducted in several multicenters. Atorvastatin reduced total cholesterol, low-density lipoprotein cholesterol, and apolipoprotein B substantially in a dose-dependent manner without any serious adverse events.